A genome-wide association meta-analysis of prognostic outcomes following cognitive behavioural therapy in individuals with anxiety and depressive disorders

[1]  G. Breen,et al.  Genetic influences on treatment-seeking for common mental health problems in the UK biobank , 2019, Behaviour research and therapy.

[2]  Blair H. Smith,et al.  Genome-wide association study of antidepressant treatment resistance in a population-based cohort using health service prescription data and meta-analysis with GENDEP , 2019, The Pharmacogenomics Journal.

[3]  P. Sullivan,et al.  Genetics of response to cognitive behavior therapy in adults with major depression: a preliminary report , 2018, Molecular Psychiatry.

[4]  Alicia R. Martin,et al.  Discovery of the first genome-wide significant risk loci for attention deficit/hyperactivity disorder , 2018, Nature Genetics.

[5]  Jonathan P. Beauchamp,et al.  Gene discovery and polygenic prediction from a genome-wide association study of educational attainment in 1.1 million individuals , 2018, Nature Genetics.

[6]  S. Linnarsson,et al.  Meta-analysis of genome-wide association studies for neuroticism in 449,484 individuals identifies novel genetic loci and pathways , 2018, Nature Genetics.

[7]  Tyrone D. Cannon,et al.  Genome-wide association meta-analysis in 269,867 individuals identifies new genetic and functional links to intelligence , 2018, Nature Genetics.

[8]  Stuart J. Ritchie,et al.  Genomic SEM Provides Insights into the Multivariate Genetic Architecture of Complex Traits , 2019, Nature Human Behaviour.

[9]  Warren W. Kretzschmar,et al.  Genome-wide association analyses identify 44 risk variants and refine the genetic architecture of major depression , 2017, Nature Genetics.

[10]  T. Werge,et al.  Genome-wide Association Study of Anxiety and Stress-related Disorders in the iPSYCH Cohort , 2018, bioRxiv.

[11]  G. Andersson,et al.  Internet-based vs. face-to-face cognitive behavior therapy for psychiatric and somatic disorders: an updated systematic review and meta-analysis , 2018, Cognitive behaviour therapy.

[12]  R. Mojtabai.  Nonremission and time to remission among remitters in major depressive disorder: Revisiting STAR*D , 2017, Depression and anxiety.

[13]  P. Visscher,et al.  Multi-trait analysis of genome-wide association summary statistics using MTAG , 2017, Nature Genetics.

[14]  G. Breen,et al.  The Common Genetic Architecture of Anxiety Disorders , 2017, bioRxiv.

[15]  P. Visscher,et al.  10 Years of GWAS Discovery: Biology, Function, and Translation. , 2017, American journal of human genetics.

[16]  G. Breen,et al.  Separate and combined effects of genetic variants and pre-treatment whole blood gene expression on response to exposure-based cognitive behavioural therapy for anxiety disorders , 2017, The world journal of biological psychiatry : the official journal of the World Federation of Societies of Biological Psychiatry.

[17]  Murray B Stein,et al.  Anxiety , 2017, The Lancet.

[18]  P. Cuijpers,et al.  How effective are cognitive behavior therapies for major depression and anxiety disorders? A meta‐analytic update of the evidence , 2016, World psychiatry : official journal of the World Psychiatric Association.

[19]  N. Lindefors,et al.  Predicting Outcome in Internet-Based Cognitive Behaviour Therapy for Major Depression: A Large Cohort Study of Adult Patients in Routine Psychiatric Care , 2016, PloS one.

[20]  Shane A. McCarthy,et al.  Reference-based phasing using the Haplotype Reference Consortium panel , 2016, Nature Genetics.

[21]  G. Breen,et al.  Quality control, imputation and analysis of genome-wide genotyping data from the Illumina HumanCoreExome microarray. , 2016, Briefings in functional genomics.

[22]  Jonathan P. Beauchamp,et al.  Genetic variants associated with subjective well-being, depressive symptoms and neuroticism identified through genome-wide analyses , 2016, Nature Genetics.

[23]  Nick C Fox,et al.  Analysis of shared heritability in common disorders of the brain , 2018, Science.

[24]  R. Rapee,et al.  A Genome-Wide Test of the Differential Susceptibility Hypothesis Reveals a Genetic Predictor of Differential Response to Psychological Treatments for Child Anxiety Disorders , 2016, Psychotherapy and Psychosomatics.

[25]  R. Rapee,et al.  Genome-wide association study of response to cognitive–behavioural therapy in children with anxiety disorders , 2016, British Journal of Psychiatry.

[26]  R. Rapee,et al.  Non-replication of the association between 5HTTLPR and response to psychological therapy for child anxiety disorders , 2016, The British journal of psychiatry : the journal of mental science.

[27]  M. Craske,et al.  Response rates for CBT for anxiety disorders: Need for standardized criteria. , 2015, Clinical psychology review.

[28]  N. Wray,et al.  Meta-analysis of genome-wide association studies of anxiety disorders , 2015, Molecular Psychiatry.

[29]  P. Joyce,et al.  Predictors of response to CBT and IPT for depression; the contribution of therapy process. , 2015, Behaviour research and therapy.

[30]  D. Bates,et al.  Linear Mixed-Effects Models using 'Eigen' and S4 , 2015 .

[31]  R. Rapee,et al.  Comparing outcomes for children with different anxiety disorders following cognitive behavioural therapy. , 2015, Behaviour research and therapy.

[32]  Frank Dudbridge,et al.  A Fast Method that Uses Polygenic Scores to Estimate the Variance Explained by Genome-wide Marker Panels and the Proportion of Variants Affecting a Trait. , 2015, American journal of human genetics.

[33]  A. Gloster,et al.  MicroRNA hsa‐miR‐4717‐5p regulates RGS2 and may be a risk factor for anxiety‐related traits , 2015, American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics.

[34]  R. Rapee,et al.  Clinical Predictors of Response to Cognitive-Behavioral Therapy in Pediatric Anxiety Disorders: The Genes for Treatment (GxT) Study , 2015, Journal of the American Academy of Child and Adolescent Psychiatry.

[35]  P. Visscher,et al.  Nature Genetics Advance Online Publication , 2022 .

[36]  J. Margraf,et al.  Changing the future, not the past: a translational paradigm shift in treating anxiety , 2015, EMBO reports.

[37]  Jack Euesden,et al.  PRSice: Polygenic Risk Score software , 2014, Bioinform..

[38]  Carson C Chow,et al.  Second-generation PLINK: rising to the challenge of larger and richer datasets , 2014, GigaScience.

[39]  G. Myhr,et al.  Predicting who benefits most from cognitive-behavioral therapy for anxiety and depression. , 2014, Journal of clinical psychology.

[40]  Per Carlbring,et al.  Guided Internet‐based vs. face‐to‐face cognitive behavior therapy for psychiatric and somatic disorders: a systematic review and meta‐analysis , 2014, World psychiatry : official journal of the World Psychiatric Association.

[41]  Naomi R. Wray,et al.  Genetic Studies of Major Depressive Disorder: Why Are There No Genome-wide Association Study Findings and What Can We Do About It? , 2014, Biological Psychiatry.

[42]  C. Rück,et al.  Effects of Baseline Problematic Alcohol and Drug Use on Internet-Based Cognitive Behavioral Therapy Outcomes for Depression, Panic Disorder and Social Anxiety Disorder , 2014, PloS one.

[43]  T. Eley.  THE FUTURE OF THERAPYGENETICS: WHERE WILL STUDIES PREDICTING PSYCHOLOGICAL TREATMENT RESPONSE FROM GENOMIC MARKERS LEAD? , 2014, Depression and anxiety.

[44]  C. Spencer,et al.  Biological Insights From 108 Schizophrenia-Associated Genetic Loci , 2014, Nature.

[45]  R. Ownby,et al.  Negative and positive beliefs related to mood and health. , 2014, American journal of health behavior.

[46]  V. Patel,et al.  The global prevalence of common mental disorders: a systematic review and meta-analysis 1980-2013. , 2014, International journal of epidemiology.

[47]  M. Daly,et al.  LD Score regression distinguishes confounding from polygenicity in genome-wide association studies , 2014, Nature Genetics.

[48]  Zachary D. Cohen,et al.  The Personalized Advantage Index: Translating Research on Prediction into Individualized Treatment Recommendations. A Demonstration , 2014, PloS one.

[49]  G. Andersson,et al.  Effectiveness of Internet‐based cognitive behaviour therapy for panic disorder in routine psychiatric care , 2013, Acta psychiatrica Scandinavica.

[50]  T. Vos,et al.  Global burden of disease attributable to mental and substance use disorders: findings from the Global Burden of Disease Study 2010 , 2013, The Lancet.

[51]  D. Collier,et al.  Predicting outcomes following cognitive behaviour therapy in child anxiety disorders: the influence of genetic, demographic and clinical information. , 2013, Journal of child psychology and psychiatry, and allied disciplines.

[52]  M. Byrne,et al.  The key principles of cognitive behavioural therapy , 2013 .

[53]  A. Young,et al.  The size, burden and cost of disorders of the brain in the UK , 2013, Journal of psychopharmacology.

[54]  K. Tansey,et al.  Contribution of Common Genetic Variants to Antidepressant Response , 2013, Biological Psychiatry.

[55]  A. Przeworski,et al.  Worry and generalized anxiety disorder: a review and theoretical synthesis of evidence on nature, etiology, mechanisms, and treatment. , 2013, Annual review of clinical psychology.

[56]  Thalia C Eley,et al.  Therapygenetics: Using genetic markers to predict response to psychological treatment for mood and anxiety disorders , 2013, Biology of Mood & Anxiety Disorders.

[57]  K. Beesdo-Baum,et al.  Developmental epidemiology of anxiety disorders. , 2012, Child and adolescent psychiatric clinics of North America.

[58]  O. Delaneau,et al.  A linear complexity phasing method for thousands of genomes , 2011, Nature Methods.

[59]  E. Walker,et al.  Diagnostic and Statistical Manual of Mental Disorders , 2013 .

[60]  Tilo Kircher,et al.  Psychological treatment for panic disorder with agoraphobia: a randomized controlled trial to examine the role of therapist-guided exposure in situ in CBT. , 2011, Journal of consulting and clinical psychology.

[61]  S. Cichon,et al.  TMEM132D, a new candidate for anxiety phenotypes: evidence from human and mouse studies , 2011, Molecular Psychiatry.

[62]  P. Visscher,et al.  GCTA: a tool for genome-wide complex trait analysis. , 2011, American journal of human genetics.

[63]  A. Beck,et al.  Cognitive theory and therapy of anxiety and depression: Convergence with neurobiological findings , 2010, Trends in Cognitive Sciences.

[64]  Wolfgang Viechtbauer,et al.  Conducting Meta-Analyses in R with the metafor Package , 2010 .

[65]  Yun Li,et al.  METAL: fast and efficient meta-analysis of genomewide association scans , 2010, Bioinform..

[66]  Per Carlbring,et al.  Internet-versus group-administered cognitive behaviour therapy for panic disorder in a psychiatric setting: a randomised trial , 2010, BMC psychiatry.

[67]  P. Muglia,et al.  Genome-wide pharmacogenetics of antidepressant response in the GENDEP project. , 2010, The American journal of psychiatry.

[68]  Jay Belsky,et al.  Beyond diathesis stress: differential susceptibility to environmental influences. , 2009, Psychological bulletin.

[69]  M. Höfler,et al.  Mechanism of action in CBT (MAC): methods of a multi-center randomized controlled trial in 369 patients with panic disorder and agoraphobia , 2009, European Archives of Psychiatry and Clinical Neuroscience.

[70]  D. Chambless,et al.  Cognitive-behavioral therapy for adult anxiety disorders in clinical practice: a meta-analysis of effectiveness studies. , 2009, Journal of consulting and clinical psychology.

[71]  S. Cichon,et al.  Genomewide association studies: history, rationale, and prospects for psychiatric disorders. , 2009, The American journal of psychiatry.

[72]  Manuel A. R. Ferreira,et al.  PLINK: a tool set for whole-genome association and population-based linkage analyses. , 2007, American journal of human genetics.

[73]  Peter J. Norton,et al.  A Meta-Analytic Review of Adult Cognitive-Behavioral Treatment Outcome Across the Anxiety Disorders , 2007, The Journal of nervous and mental disease.

[74]  P. Joyce,et al.  Patient predictors of response to interpersonal psychotherapy and cognitive behaviour therapy , 2006, Acta Neuropsychiatrica.

[75]  S. Luty,et al.  Screening and treatment for depression during pregnancy: a cautionary note , 2006, Acta Neuropsychiatrica.

[76]  D. Reich,et al.  Principal components analysis corrects for stratification in genome-wide association studies , 2006, Nature Genetics.

[77]  Olga V. Demler,et al.  Lifetime prevalence and age-of-onset distributions of DSM-IV disorders in the National Comorbidity Survey Replication. , 2005, Archives of general psychiatry.

[78]  D I Boomsma,et al.  The co-morbidity of anxiety and depression in the perspective of genetic epidemiology. A review of twin and family studies , 2005, Psychological Medicine.

[79]  Olga V. Demler,et al.  The epidemiology of major depressive disorder: results from the National Comorbidity Survey Replication (NCS-R). , 2003, JAMA.

[80]  David L Streiner,et al.  Breaking up is Hard to Do: The Heartbreak of Dichotomizing Continuous Data , 2002, Canadian journal of psychiatry. Revue canadienne de psychiatrie.

[81]  M K Shear,et al.  Reliability and validity of the Panic Disorder Severity Scale: replication and extension. , 2001, Journal of psychiatric research.

[82]  Andrew J Vickers,et al.  The use of percentage change from baseline as an outcome in a controlled trial is statistically inefficient: a simulation study , 2001, BMC medical research methodology.

[83]  C. Bell.  Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition, Text Revision: DSM-IV-TR Quick Reference to the Diagnostic Criteria from DSM-IV-TR , 2001 .

[84]  P. Sullivan,et al.  Genetic epidemiology of major depression: review and meta-analysis. , 2000, The American journal of psychiatry.

[85]  P. Schuster,et al.  The waxing and waning of mental disorders: evaluating the stability of syndromes of mental disorders in the population. , 2000, Comprehensive psychiatry.

[86]  R. Kessler,et al.  The World Health Organization Composite International Diagnostic Interview short‐form (CIDI‐SF) , 1998 .

[87]  M K Shear,et al.  Multicenter collaborative panic disorder severity scale. , 1997, The American journal of psychiatry.

[88]  B. Bandelow,et al.  Assessing the efficacy of treatments for panic disorder and agoraphobia. II. The Panic and Agoraphobia Scale , 1995, International clinical psychopharmacology.

[89]  E. Rüther,et al.  Assessing the efficacy of treatments for panic disorder and agoraphobia. I. Methodological problems , 1995, International clinical psychopharmacology.

[90]  P. Svanborg,et al.  A new self‐rating scale for depression and anxiety states based on the Comprehensive Psychopathological Rating Scale , 1994, Acta psychiatrica Scandinavica.

[91]  M C Neale,et al.  Major depression and generalized anxiety disorder. Same genes, (partly) different environments? , 1992, Archives of general psychiatry.

[92]  Christopher S. Poultney,et al.  Meta-analysis of GWAS of over 16,000 individuals with autism spectrum disorder highlights a novel locus at 10q24.32 and a significant overlap with schizophrenia , 2017, Molecular Autism.

[93]  Lars-Göran Öst,et al.  Predictors of treatment outcome in an effectiveness trial of cognitive behavioral therapy for children with anxiety disorders. , 2016, Behaviour research and therapy.

[94]  R Core Team,et al.  R: A language and environment for statistical computing. , 2014 .

[95]  Patricia A. Berglund,et al.  The Epidemiology of Major Depressive Disorder , 2009 .

[96]  J. Margraf,et al.  Diagnostisches Interview bei psychischen Störungen (DIPS) , 2006 .

[97]  Pak Chung Sham,et al.  Genetic Power Calculator: design of linkage and association genetic mapping studies of complex traits , 2003, Bioinform..

[98]  Michael J. Lambert,et al.  Research summary on the therapeutic relationship and psychotherapy outcome. , 2001 .

[99]  D. Sheehan,et al.  The Mini-International Neuropsychiatric Interview (M.I.N.I.): the development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10. , 1998, The Journal of clinical psychiatry.

[100]  J. Margraf,et al.  Glossar der wichtigsten mit dem DIPS: Diagnostisches Interview bei psychischen Störungen diagnostizierbaren Störungen , 1994 .

[101]  J. Margraf,et al.  Dips: Diagnostisches Interview Bei Psychischen Storungen , 1994 .